Dina N Alcorn

Title: Dina N Alcorn: Innovator in Immunology

Introduction

Dina N Alcorn is a prominent inventor based in Tacoma, WA (US). She has made significant contributions to the field of immunology, particularly through her innovative work on interleukin-2 muteins. With a total of 2 patents, her research focuses on enhancing the expansion and activation of T regulatory cells.

Latest Patents

Dina's latest patents include groundbreaking developments in interleukin-2 muteins for the expansion of T-regulatory cells. These patents provide IL-2 muteins, IL-2 mutein Fc-fusion molecules, anti-IL-2 antibodies, and complexes that preferentially expand and activate T regulatory cells. The inventions are designed to be amenable to large-scale production. Additionally, her patents describe variant human IgG1 Fc molecules that maintain high stability despite lacking glycosylation at N297. The patents also include methods for making and using these innovative compositions.

Career Highlights

Dina N Alcorn is currently associated with Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to push the boundaries of immunological research and contribute to advancements in therapeutic applications.

Collaborations

Dina has collaborated with notable colleagues, including Eric Alan Butz and Christy Ann Thomson. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Dina N Alcorn's contributions to immunology through her patents and work at Amgen Inc. highlight her role as a key innovator in the field. Her research continues to pave the way for advancements in therapeutic strategies targeting T regulatory cells.